The ³Ô¹ÏÍøÕ¾ Clinical Terminology Service (NCTS) is pleased to announce that the September combined release of SNOMED CT®-AU1 and the Australian Medicines Terminology (AMT) is now available to registered users from the .
Important Information
Third party reference sets
List of Medicines for Brand Consideration reference set
Produced by the Australian Government Department of Health, this reference set enables software vendors to identify AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP) concepts associated with the List of Medicines for Brand Consideration (LMBC) under The ³Ô¹ÏÍøÕ¾ Health (Pharmaceutical Benefits) Amendment (Active ingredient Prescribing) Regulations 2019 and The Veterans’ Affairs Pharmaceutical Benefits Schemes (Electronic Prescriptions and Active Ingredient Prescribing) Amendment Instrument 2019.
Electronic Recording and Reporting of Controlled Drugs
The following reference sets have been expanded to include AMT Medicinal Product Unit of Use (MPUU) and Medicinal Product Pack (MPP). Only the refset content has been expanded with no change to the existing format and the word ‘trade’ has been removed from the refset name.
- Schedule 8 medications;
- South Australia reportable Schedule 4 medications;
- Tasmania reportable Schedule 4 medications;
- Victoria reportable Schedule 4 medications; and
- Queensland Health QScript Schedule 4 monitored medicines
The full description of the above reference sets can be viewed by selecting it within from the tab.
Document Library update
The following document has been added to the :
Please refer to the in
